MedTrace Logo

PROPER Trial of Pain and Inflammation After Knee Arthroscopy

NCT05149287 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-09-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if ceftriaxone administered postoperatively via intravenous injection reduces postoperative visual analog scale (VAS) pain scores and narcotic consumption in patients undergoing knee arthroscopy for a cartilage or meniscal injury.

Conditions

  • Meniscus Tear
  • Meniscus Lesion
  • Cartilage Injury

Interventions

DRUG

Ceftriaxone

single intravenous dose of 1 g of ceftriaxone

OTHER

Placebo

1% lidocaine and saline

Sponsors & Collaborators

  • Austin V Stone

    lead OTHER

Principal Investigators

  • Austin V Stone, MD, PhD · University of Kentucky

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-28
Primary Completion
2022-04-29
Completion
2022-04-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05149287 on ClinicalTrials.gov